We are live on ! Find out more
SGAM

Smith Group Asset Management Portfolio holdings

AUM $2.46B
1-Year Est. Return 57.16%
This Fund
S&P 500
This Quarter Est. Return
+14.79%
1 Year Est. Return
+57.16%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$2.18B
AUM Growth
+$203M
Cap. Flow
-$31.5M
Cap. Flow %
-1.45%
Top 10 Hldgs %
35.11%
Holding
404
New
36
Increased
94
Reduced
108
Closed
38

Top Buys

Rank Stock Value
1
ZBRA icon
Zebra Technologies
ZBRA
+$32.8M
2
PFE icon
Pfizer
PFE
+$24.5M
3
AXP icon
American Express
AXP
+$24.2M
4
EPAM icon
EPAM Systems
EPAM
+$16.4M
5
MRK icon
Merck
MRK
+$16.1M

Top Sells

Rank Stock Value
1
PYPL icon
PayPal
PYPL
+$24.3M
2
EHC icon
Encompass Health
EHC
+$24M
3
USB icon
US Bancorp
USB
+$21.9M
4
EG icon
Everest Group
EG
+$18.7M
5
ETN icon
Eaton
ETN
+$17.7M

Sector Composition

Rank Sector Weight
1 Technology 33.85%
2 Healthcare 14.97%
3 Consumer Discretionary 12.67%
4 Financials 10.15%
5 Industrials 9.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KOD icon
351
Kodiak Sciences
KOD
$2.72B
$3K ﹤0.01%
40
PTCT icon
352
PTC Therapeutics
PTCT
$6.23B
$3K ﹤0.01%
70
CAMP
353
DELISTED
CalAmp Corp.
CAMP
$3K ﹤0.01%
16
KRTX
354
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$3K ﹤0.01%
20
BBIO icon
355
BridgeBio Pharma
BBIO
$16.6B
$2K ﹤0.01%
100
EDIT icon
356
Editas Medicine
EDIT
$432M
$2K ﹤0.01%
90
TGTX icon
357
TG Therapeutics
TGTX
$7.52B
$2K ﹤0.01%
120
XNCR icon
358
Xencor
XNCR
$1.6B
$2K ﹤0.01%
60
NVTA
359
DELISTED
Invitae Corporation
NVTA
$2K ﹤0.01%
130
KYNB
360
Kyntra Bio
KYNB
$28.2M
$1K ﹤0.01%
3
HRTX icon
361
Heron Therapeutics
HRTX
$63.4M
$1K ﹤0.01%
120
ACGL icon
362
Arch Capital
ACGL
$33.5B
-376,159
Closed -$14.4M
ALL icon
363
Allstate
ALL
$68.2B
-354
Closed -$45K
ALLK
364
DELISTED
Allakos
ALLK
$0 ﹤0.01%
30
BC icon
365
Brunswick
BC
$5.21B
-8,700
Closed -$829K
BKR icon
366
Baker Hughes
BKR
$63.6B
-888
Closed -$22K
CDW icon
367
CDW
CDW
$17.1B
-1,670
Closed -$304K
CGNX icon
368
Cognex
CGNX
$10.8B
-60,029
Closed -$4.82M
CORT icon
369
Corcept Therapeutics
CORT
$12.3B
-27,422
Closed -$540K
CRI icon
370
Carter's
CRI
$1.48B
-123,000
Closed -$12M
EAT icon
371
Brinker International
EAT
$9.76B
-8,846
Closed -$4.34M
EG icon
372
Everest Group
EG
$14.2B
-746
Closed -$18.7M
EHC icon
373
Encompass Health
EHC
$12.5B
-402,025
Closed -$24M
EL icon
374
Estee Lauder
EL
$31.5B
-785
Closed -$235K
EMN icon
375
Eastman Chemical
EMN
$8.39B
-144
Closed -$15K

Similar funds

Smith Group Asset Management's Q4 2021 Portfolio in Review

As of Q4 2021, Smith Group Asset Management held 404 positions worth $2.18B, up 10% from $1.97B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Smith Group Asset Management's Q4 2021 filing shows 36 new, 94 increased, 108 reduced and 38 closed positions. Its largest new stake was AutoNation: 130,907 shares worth $15.3M. The largest sale was PayPal, an estimated $24.3M.

By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 32% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Smith Group Asset Management's largest Q4 2021 buy was AutoNation: 130,907 shares worth $15.3M.
  • Smith Group Asset Management added most to Zebra Technologies in Q4 2021, an estimated $32.8M increase.
  • Smith Group Asset Management's biggest Q4 2021 reduction was US Bancorp, cutting an estimated $21.9M.
  • Smith Group Asset Management fully exited PayPal in Q4 2021, selling an estimated $24.3M.
  • Smith Group Asset Management's ten largest holdings make up 35% of its $2.18B portfolio in Q4 2021.
  • Smith Group Asset Management opened 36 new positions and closed 38 in Q4 2021.
  • Smith Group Asset Management's portfolio value rose 10% quarter-over-quarter to $2.18B.

Based on Smith Group Asset Management's 13F filing for Q4 2021, filed 2 Feb 2022.